Halozyme Therapeutics, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
HALO Nasdaq 2836 halozyme.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Halozyme Therapeutics, Inc.

JPMorgan says large-cap biotech is back as profits and pipelines fuel upside - May 28th, 2026 2:27 pm
Is MYGN Stock a Buy at 0.4x Sales? What Investors Should Weigh - May 28th, 2026 7:20 am
Implied Volatility Surging for Halozyme Therapeutics Stock Options - May 26th, 2026 7:29 am
Assessing Halozyme Therapeutics (HALO) Valuation After Mixed Short Term And Strong Multi Year Share Returns - May 25th, 2026 11:07 pm
Halozyme Therapeutics’s Q1 Earnings Call: Our Top 5 Analyst Questions - May 19th, 2026 5:40 pm
3 Growth Stocks Set to Flourish - May 19th, 2026 6:12 am
Thermo Fisher, Dentsply Sirona, Collegium Pharmaceutical, and Halozyme Therapeutics Stocks Trade Down, What You Need To Know - May 17th, 2026 3:40 am
Therapeutics Stocks Q1 Recap: Benchmarking Halozyme Therapeutics (NASDAQ:HALO) - May 16th, 2026 5:08 am
HALO Q1 Deep Dive: Royalty Expansion and Pipeline Progress Shape 2026 Outlook - May 15th, 2026 2:20 pm
Halozyme Therapeutics Earnings: What To Look For From HALO - May 13th, 2026 3:32 am
Company News for May 13, 2026 - May 13th, 2026 3:23 am
Halozyme Therapeutics (HALO) Announces Global Collaboration and License Agreement With GSK - May 12th, 2026 3:28 pm
Halozyme Q1 Beat Driven by Royalty Outperformance, Strong Demand, Morgan Stanley - May 12th, 2026 9:54 am
Halozyme Therapeutics Inc (HALO) Q1 2026 Earnings Call Highlights: Record Revenue Growth and ... - May 12th, 2026 1:06 am
Halozyme Therapeutics Q1 Earnings Call Highlights - May 11th, 2026 6:09 pm
Halozyme Therapeutics (HALO) Reports Q1 Earnings: What Key Metrics Have to Say - May 11th, 2026 3:30 pm
Halozyme Therapeutics (HALO) Surpasses Q1 Earnings and Revenue Estimates - May 11th, 2026 3:15 pm
Halozyme Therapeutics’s (NASDAQ:HALO) Q1 CY2026 Sales Top Estimates - May 11th, 2026 2:06 pm
H.C. Wainwright Bullish on Halozyme Therapeutics, Inc. (HALO) Commercial Revenue Outlook - May 11th, 2026 2:05 pm
HALOZYME REPORTS FIRST QUARTER 2026 RESULTS AND REITERATES 2026 FINANCIAL GUIDANCE - May 11th, 2026 2:01 pm